# Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

> **NCT03957083** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 30 (actual)

## Conditions studied

- Postpartum Hemorrhage
- Obesity

## Interventions

- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT03957083
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-26
- **Primary completion:** 2020-02-03
- **Final completion:** 2020-02-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03957083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03957083, "Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03957083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*